|
|
|
1 Brain Death and Degenerative Diseases |
|
|
3 | (4) |
|
|
|
|
2 Cerebrovascular Diseases |
|
|
7 | (8) |
|
|
|
|
15 | (5) |
|
|
|
|
4 Neuromuscular Disorders |
|
|
20 | (4) |
|
|
|
5 Increased Intracranial Pressure |
|
|
24 | (6) |
|
|
|
|
30 | (10) |
|
|
|
|
|
40 | (3) |
|
|
|
8 Encephalopathy Delirium |
|
|
43 | (6) |
|
|
Jeanine P. Wiener-Kronish |
|
|
|
49 | (7) |
|
|
|
10 Inflammatory Demyelinating |
|
|
56 | (5) |
|
|
|
|
|
61 | (3) |
|
|
|
12 Analgesia, Sedation Neuromuscular Blockade |
|
|
64 | (4) |
|
|
|
13 Neuro Monitoring Diagnostic Modalities |
|
|
68 | (7) |
|
|
|
|
|
75 | (10) |
|
|
|
II Cardiovascular Disorders |
|
|
|
15 Acute Coronary Syndrome |
|
|
85 | (11) |
|
|
|
|
96 | (8) |
|
|
|
|
104 | (4) |
|
|
|
|
108 | (8) |
|
|
|
19 Valvular Heart Disease |
|
|
116 | (9) |
|
|
|
|
125 | (7) |
|
|
|
|
132 | (5) |
|
|
|
22 Congenital Heart Disease in Adults |
|
|
137 | (3) |
|
|
|
|
140 | (7) |
|
|
|
24 Mechanical Circulatory Support the Transplanted Heart |
|
|
147 | (5) |
|
|
|
25 Calculated Cardiovascular Parameters |
|
|
152 | (4) |
|
|
|
|
26 Life Support Resuscitation |
|
|
156 | (6) |
|
|
|
27 Imaging Diagnostic Modalities |
|
|
162 | (7) |
|
|
|
|
169 | (8) |
|
|
|
29 Management Strategies (Coagulation, Vasoactive Medications) |
|
|
177 | (8) |
|
|
|
|
|
|
185 | (8) |
|
|
31 Hypoxemia Oxygen Delivery |
|
|
193 | (9) |
|
|
Jeanine P. Wiener-Kronish |
|
|
32 Mechanical Ventilation |
|
|
202 | (7) |
|
|
|
33 Acute Respiratory Distress Syndrome |
|
|
209 | (7) |
|
|
Jeanine P. Wiener-Kronish |
|
|
34 Other Parenchymal Disease Pulmonary Edema |
|
|
216 | (6) |
|
|
|
|
|
222 | (8) |
|
|
|
36 Diseases of the Chest Wall |
|
|
230 | (4) |
|
|
|
37 Thromboembolic Disease Hemoptysis |
|
|
234 | (5) |
|
|
|
|
|
239 | (3) |
|
|
|
242 | (3) |
|
|
|
|
|
245 | (7) |
|
|
|
|
252 | (6) |
|
|
|
42 Lung Transplantation, Complications, VV ECMO |
|
|
258 | (6) |
|
|
|
43 Respiratory Diagnostic Modalities, Monitoring |
|
|
264 | (13) |
|
|
|
|
|
IV Renal, Electrolyte, Acid Base Disorders |
|
|
|
|
277 | (6) |
|
|
|
|
|
283 | (5) |
|
|
|
|
|
|
|
|
|
46 Renal Replacement Therapy |
|
|
288 | (5) |
|
|
|
|
47 Drug Dosing in Renal Failure |
|
|
293 | (4) |
|
|
|
|
|
|
297 | (3) |
|
|
49 Diagnosis Monitoring in Renal Failure |
|
|
300 | (6) |
|
|
|
|
|
|
|
|
|
|
306 | (8) |
|
|
|
|
314 | (5) |
|
|
|
52 Calcium, Phosphate, Magnesium |
|
|
319 | (5) |
|
|
|
|
324 | (17) |
|
|
|
|
|
|
341 | (6) |
|
|
|
347 | (5) |
|
|
|
|
352 | (3) |
|
|
|
355 | (5) |
|
|
|
360 | (3) |
|
|
59 Renin-Angiotensin-Aldosterone System |
|
|
363 | (3) |
|
|
60 Hypothalamic-Pituitary-Adrenal Axis |
|
|
366 | (5) |
|
|
61 Management During Critical Illness |
|
|
371 | (8) |
|
|
VI Infections, Immunologic Disease |
|
|
|
|
379 | (6) |
|
|
|
385 | (9) |
|
Nitin Das Kunnathu Puthanveedu |
|
|
|
64 Head and Neck Upper Airway Infections |
|
|
394 | (3) |
|
|
65 Cardiovascular Infections |
|
|
397 | (3) |
|
|
66 Gastrointestinal Intra-abdominal Infections |
|
|
400 | (7) |
|
|
|
67 Genitourinary Infection |
|
|
407 | (3) |
|
|
68 Soft-Tissue, Bone, Joint Infections |
|
|
410 | (4) |
|
|
69 Antimicrobial Therapy Resistance |
|
|
414 | (6) |
|
|
70 Immune Suppression: Congenital, Acquired, Drugs |
|
|
420 | (7) |
|
|
|
71 Infections in the Immunocompromised Host |
|
|
427 | (9) |
|
|
|
|
|
|
72 Immunological Effects of Infections |
|
|
436 | (5) |
|
|
|
|
441 | (3) |
|
|
74 Hospital Infection Control, Hospital Acquired Infections |
|
|
444 | (5) |
|
|
75 Immunological Diseases |
|
|
449 | (10) |
|
|
VII Hematologic Oncologic Disorders |
|
|
|
|
459 | (5) |
|
|
77 White Blood Cell Disorders |
|
|
464 | (5) |
|
|
|
469 | (4) |
|
|
|
|
473 | (6) |
|
|
|
80 Hypercoagulable States |
|
|
479 | (3) |
|
|
|
482 | (4) |
|
|
|
|
486 | (4) |
|
|
|
|
490 | (4) |
|
|
|
84 Hemopoietic Cell Transplantation |
|
|
494 | (4) |
|
|
85 Complications of Immunosuppressive Drugs Chemotherapy |
|
|
498 | (5) |
|
|
VIII Gastrointestinal, Nutrition Genitourinary Disorders |
|
|
|
|
503 | (4) |
|
|
|
|
507 | (3) |
|
|
|
|
510 | (4) |
|
|
|
|
514 | (4) |
|
|
|
|
518 | (5) |
|
|
|
91 Gallbladder Biliary Tract |
|
|
523 | (3) |
|
|
|
|
526 | (5) |
|
|
|
|
531 | (4) |
|
|
|
94 Diagnostic Management Modalities |
|
|
535 | (6) |
|
|
|
95 Nutrition in Critical Illness |
|
|
541 | (6) |
|
|
IX Surgery, Trauma, Transplantation |
|
|
|
96 Cardiothoracic Vascular Surgery |
|
|
547 | (12) |
|
|
|
|
|
|
|
97 Abdominal Gastrointestinal Surgery |
|
|
559 | (6) |
|
|
98 Skin, Soft Tissue, Extremities |
|
|
565 | (5) |
|
|
|
|
570 | (10) |
|
|
|
100 Hemorrhage Resuscitation |
|
|
580 | (6) |
|
|
|
|
586 | (6) |
|
|
|
|
592 | (6) |
|
|
|
|
|
598 | (7) |
|
|
|
|
605 | (10) |
|
|
|
|
X Pharmacology Toxicology |
|
|
|
105 Basic Pharmacologic Principles |
|
|
615 | (5) |
|
|
|
106 Adverse Effects of Drugs |
|
|
620 | (5) |
|
|
|
|
625 | (10) |
|
|
|
|
635 | (5) |
|
|
|
109 Metabolism Drug Interactions |
|
|
640 | (6) |
|
|
|
110 Toxicology Drugs of Addiction |
|
|
646 | (8) |
|
|
|
111 Psychoactive Medications |
|
|
654 | (5) |
|
|
|
XI Research, Administration, Ethics |
|
|
|
112 Research Biostatistics |
|
|
659 | (6) |
|
|
|
665 | (9) |
|
|
|
|
674 | (3) |
|
|
115 Psychosocial Issue Among Providers |
|
|
677 | (2) |
|
|
|
116 Ethical Considerations |
|
|
679 | (3) |
|
|
|
|
117 Patient Confidentiality, Healthcare Policy |
|
|
682 | (3) |
|
|
118 Palliative Care End of Life |
|
|
685 | (7) |
|
|
|
|
692 | (5) |
|
|
|
|
|
|
697 | (8) |
|
|
|
|
705 | (4) |
|
|
|
122 Dermatological Disorders |
|
|
709 | (8) |
|
|
|
123 Thermoregulatory Disorders |
|
|
717 | (4) |
|
|
Appendix: Grab Bag |
|
721 | (54) |
|
|
|
|
|
|
|
Index |
|
775 | |